Mettler-Toledo International, Inc. MTD
1,511.64
(7.51)
(0.49%)
as of 25 Sep
- Market cap
- $30.4B
- P/E
- 33.9×
Follow MTD
Indexes
indicate stock being part of an index
Mettler-Toledo International, Inc. (MTD) Net income
Mettler-Toledo International, Inc.'s net income for fiscal 2025 was $869.2M, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $905.6M. Over the past ten years it has ranged from $352.8M (fiscal 2015) to $872.5M (fiscal 2022); the current reading is higher than 91% of that period. Mettler-Toledo International, Inc. ranks 8th of 52 Diagnostics & Research companies by net income.
Net income, annual
Annual
| Period | Net income | Change |
|---|---|---|
| FY2025 | $869.2M | 0.70% |
| FY2024 | $863.1M | 9.43% |
| FY2023 | $788.8M | (9.60%) |
| FY2022 | $872.5M | 13.46% |
| FY2021 | $769.0M | 27.58% |
| FY2020 | $602.7M | 7.42% |
| FY2019 | $561.1M | 9.46% |
| FY2018 | $512.6M | 36.34% |
| FY2017 | $376.0M | (2.18%) |
| FY2016 | $384.4M | 8.94% |
Quarterly
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $232.9M | 37.44% |
| Mar 2026 | $169.5M | (40.70%) |
| Dec 2025 | $285.8M | 31.39% |
| Sep 2025 | $217.5M | 7.48% |
| 42 more quarters | Free account |
Against its own ten years
Low $352.8M
High $872.5M
Ten-year median
$602.7M
Current reading's percentile
91
Net income against peers
| Company | Net income |
|---|---|
| A Agilent Technologies, Inc. compare | $1.4B |
| IQV IQVIA Holdings Inc. compare | $1.4B |
| IDXX IDEXX Laboratories, Inc. compare | $1.1B |
| DGX Quest Diagnostics Incorporated compare | $1.1B |
| LH Labcorp Holdings Inc. compare | $1.0B |
| MTD Mettler-Toledo International, Inc. | $905.6M |
| ILMN Illumina, Inc. compare | $824.0M |
| WAT Waters Corporation compare | $166.6M |
| GH Guardant Health, Inc. compare | −$453.4M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on MTD
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement